Vithas Nuestra Señora de Fatima hospital since October has been a pioneer hospital in Vigo to have a Robotic Surgery Unit led by Dr Manuel Ruibal. The unit features the Da Vinci surgical robot which improves the results, accuracy and safety of surgical acts. In the case of prostate surgeries, it also reduces the likelihood of possible incontinence or impotence.
The Da Vinci Surgical System is an important investment in technology and the quality of healthcare. Nuestra Señora de Fatima Hospital belongs to the Vithas health group, which has 19 hospitals and 29 medical centres in Spain.
This robotic system is the most innovative platform today for minimally invasive surgery which is revolutionising the medicine. It is used for surgeries in urology, oncological gynaecology, thoracic, cardiovascular and general surgery and otorhinolaryngology.
With the da Vinci robot, the surgeon does not operate directly on the patient but does so from a console handling tiny wristed instruments. 3D high-definition vision is increased up to 10 times, allowing the surgeon to work with greater accuracy. The system translates the movements of the doctor's hands into impulses that are transmitted to the robotic arms allowing them to reach areas that are difficult to achieve.
“The advantages of the robotic surgery are unquestionable. It allows major operations to be performed using small incisions. The benefits of robotic surgery include lower intraoperative blood loss, lower postoperative pain, shorter hospital stay, and faster recovery,” explains Dr Manuel Ruibal, Head of the Robotic Surgery Unit at Vithas Nuestra Señora de Fatima Hospital. “Using the robot, we can easier access more complicated areas, with excellent visualisation of body parts and tissue planes, eliminating physiological tremor or involuntary movements of the surgeon, as well as postural fatigue after long hours of intervention,” he adds.
These advantages have a direct impact on the patient since the size of the incisions is smaller, resulting in a better and shorter post-operative period, less pain, fewer chances of complications and, in short, faster incorporation into daily life.
The da Vinci Surgical System consists of 3 key features: the ergonomically designed surgeon console, the patient-side cart and the vision cart.
· Using the console, positioned outside the sterile field, the surgeon controls the 3D endoscope, which displays a high-definition image of the operating area and instruments.
· The patient-side cart is the operational component of the da Vinci Surgical System and consists of 4 arms designed to support the surgical instruments and the endoscope. On the back side, there are a touchpad and control buttons to select the type of intervention, depending on which the robotic arms will be automatically positioned.
· The vision cart contains the central unit for image elaboration and processing through a 24-inch touchscreen monitor, an ERBE VIO dV electrical scalpel and a high-definition video system (full HD).
The da Vinci Surgical System is a breakthrough of ABEX Excelencia Robotica and is essential in a large number of surgeries, being especially suitable for those with a high degree of complexity, where the surgical field is limited and difficult to access, as well as in surgical manoeuvres that require high precision.
Worldwide there are currently 4,400 da Vinci robots installed. In 2017, 900,000 surgical interventions were performed globally using this type of surgical system.
Vithas Nuestra Señora de Fatima Hospital
Since its foundation in 1963, Vithas Nuestra Señora de Fátima Hospital in Vigo has been a medical centre of excellence in private healthcare in the South of Galicia. It currently has a workforce of more than 400 professionals working in an area of 25,000 square metres (173 beds, 9 operating rooms and 7 ICU posts).
ABEX Excelencia Robotica
Established in 2016, ABEX Excelencia Robotica is a Spanish company operating on the Iberian Peninsula, distributing the da Vinci robotic systems.
It is part of the Ab Medica Group, an Italian company founded in 1984, a leader in the production and distribution of the most innovative medical technologies and a benchmark in robotic surgery. Ab Medica has acquired a leading role in the field of research and development, with important projects and solutions in sectors such as genomics and tissue engineering. The Group is actively working together with universities, research centres and international scientific laboratories.
The Vithas Promise: High quality accredited healthcare, personalised service and long-term commitment
Vithas is the first healthcare operator with 100 por ciento Spanish capital. Its strategic commitment is defined by supporting the healthcare with the standards of quality accreditation of the highest international prestige, the Joint Commission International. Only 14 prestigious hospitals in Spain have such accreditation and recognition, and two of them are part of Vithas, in Madrid and Malaga. Each year Vithas cares for more than 5.000.000 patients in its 19 hospitals and 29 medical centres called Vithas Salud. The 48 centres are distributed throughout the country and include hospitals in Alicante, Almeria, Benalmadena, Castellon, Granada, Las Palmas de Gran Canaria, Lleida, Madrid, Malaga, Sevilla, Tenerife, Vigo, Valencia and Vitoria- Gasteiz. The 29 Vithas Salud centres are located in Alicante, Almuñecar, Elche, El Ejido, Fuengirola, Granada, La Estrada, Las Palmas de Gran Canaria, Lleida, Madrid, Malaga, Marin, Nerja, Pontevedra, Rincon de la Victoria, Sanxenxo, Sevilla, Torre del Mar, Torremolinos, Vilagarcia, and Vitoria-Gasteiz. Vithas also counts upon more than 300 extraction points spread throughout Spain thanks to its network of Vithas Lab laboratories. Its own central purchasing office, PlazaSalud24, as a leader in the sector, provides service to 39 hospitals, 35 medical centres and 20 dental clinics.
Vithas has a strategic agreement with a hospital leader in the Balearic Islands, the Juaneda Healthcare Network, which has 5 hospitals and a wide network of medical centres throughout the region.
Vithas' commitment to accredited quality healthcare and personalised service goes hand in hand with the firm support and long-term vision of Vithas' shareholders: Goodgrower, who control 80 por ciento of the capital, and the' La Caixa' group, with the remaining 20 por ciento. With a growth model based on geographical diversification and sustainability, Vithas plans to continue consolidating its national presence both by opening new centres and through acquisitions and strategic agreements.